Cargando…
Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer
Deregulated expression of the MET receptor tyrosine kinase has been reported in up to 50% of patients with hepatocellular carcinoma, the most abundant form of liver cancers, and is associated with decreased survival. Consequently, MET is considered as a molecular target in this malignancy, whose pro...
Autores principales: | Piguet, Anne-Christine, Medová, Michaela, Keogh, Adrian, Glück, Astrid A., Aebersold, Daniel M., Dufour, Jean-François, Zimmer, Yitzhak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575919/ https://www.ncbi.nlm.nih.gov/pubmed/26413215 |
Ejemplares similares
-
PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models
por: Nisa, Lluís, et al.
Publicado: (2017) -
The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response — Biological and Clinical Aspects
por: Medová, Michaela, et al.
Publicado: (2013) -
Deciphering MET‐dependent modulation of global cellular responses to DNA damage by quantitative phosphoproteomics
por: Bensimon, Ariel, et al.
Publicado: (2020) -
A DNA-PK phosphorylation site on MET regulates its signaling interface with the DNA damage response
por: Koch, Jonas P., et al.
Publicado: (2023) -
The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer
por: Poliaková, Michaela, et al.
Publicado: (2018)